期刊文献+

38例胃肠道间质瘤临床诊治及预后影响因素 被引量:1

Clinical treatment and prognosis of 38 cases of gastrointestinal stromal tumor
原文传递
导出
摘要 目的探讨胃肠道间质瘤(GIST)的临床治疗及其预后影响因素。方法回顾分析2008年1月-2015年12月38例经手术治疗GIST患者的临床病例资料,比较相关因素对患者预后的影响。结果38例患者中男27例,女11例,中位年龄56.5岁,肿瘤位于胃24例,小肠9例,食管1例,结直肠4例,患者随访时间1-60个月,随访期间5例(13.3%)发生术后复发和(或)转移。Logistic回归分析显示,肿瘤部位、大小、肿瘤是否破裂和核分裂像与GIST患者预后有关。COX回归模型显示,肿瘤部位和核分裂像是影响GIST患者预后的独立因素(P<0.05)。结论 GIST缺乏特异性临床表现,肿瘤部位和核分裂像是影响GIST患者预后的独立危险因素。 Objective To study the clinical characteristics, treatment and prognostic factors of gastrointestinal stromal tumor. Methods By retrospective analysis from January 2008 to December 2015 Hangshan Municipal′s people Hospital 38 cases of surgical treatment of patient with GIST clinical data to compare related factors on the prognosis of patients. Results Among 38 cases, 27 were men, 11 were women, and the median age was 56.5 years of age. 24 cases were located in the stomach, 9 cases in small intestine 4 in colorectal 4, 1 in esophagus ease. Patients with follow-up of 1-60 mouths, there were 5 cases (13.3%) occurred during follow-up postoperative recurrence and (or) transfer 1 cases died. Logistic regression analysis showed that tumor site size tumor rupture and fission as related to the prognosis of patient with GIST.COX regression model shows that the tumor site and fission like the indcpendent risk factors affecting the prognosis of patient with GIST (P〈0.05). Conclusion Tumor site and fission like independent risk factors affecting the prognosis of patients with GIST.
作者 张华平
出处 《热带医学杂志》 CAS 2016年第10期1290-1292,共3页 Journal of Tropical Medicine
关键词 胃肠道间质瘤 核分裂像 预后因素 Gastrointestinal stromal tumor Mitotic count Prognostic factors
  • 相关文献

参考文献7

  • 1刘彤,赵智成.复发性胃肠间质瘤诊治对策及评价[J].中国实用外科杂志,2015,35(4):407-411. 被引量:4
  • 2Fletcher CD, Berman J J, Corless C, et al. Diagnosis of gastrointestinal stromal tumors : A consensus approach [ J ]. Hum Pathol, 2002,33 (5) :459-465.
  • 3沈旺,王新允,郑海燕,武力,袁海洪.胃肠道及胃肠道外间质瘤216例临床病理学特点分析[J].中国实用外科杂志,2011,31(8):693-695. 被引量:16
  • 4Mietteinen M, Lasota J. Gastrointestinal stromal tmnors-Definition clinical ,histological immunohistochemical and molecular genetic features and differential diagnosis [J]. Virchows Arch,2001,438 (1):1-12.
  • 5Okai T, Minamoto T, ohtsubo K, et al. Endosonographic evaluation of c-kit-positive gastrointestinal stromal tumor[J]. Abdow Lmaging, 2003,28 (3) : 301-307.
  • 6Demetri GD,von Mehren M,Antonescu GR,et al. NCCN Task Force report:update on the management of patients with gastrointestinal stromal tumors [J].J Natl Compr Canc Netw, 2010,8 Suppl 2 : S1-41.
  • 7Parfitt JR, Streutker CJ, Riddel RH, et al. Gastrointestinal stromol tumor : a contermporary review [ J ]. Pathol Res Pract, 2006,202 (12) : 383-387.

二级参考文献28

  • 1Brian K. P. Goh,Pierce K. H. Chow,Sittampalam M. Kesavan,Wai-Ming Yap,Yaw-Fui A. Chung,Wai-Keong Wong.A Single-Institution Experience with Eight CD117-Positive Primary Extragastrointestinal Stromal Tumors: Critical Appraisal and a Comparison with Their Gastrointestinal Counterparts[J]. Journal of Gastrointestinal Surgery . 2009 (6)
  • 2Abbas Agaimy,Peter H. Wünsch.Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation[J]. Langenbeck’s Archives of Surgery . 2006 (4)
  • 3Demetri GD,Benjamin RS,Blanke CD,et al.NCCN Task Force report:management of patients with gastrointestinal stromal tumor(GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw . 2007
  • 4Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathologyand prognosis at different sites[j]. Semin Diagn Pathol,2006,23(2):70-83.
  • 5DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointes-tinal stromal tumors: Recurrence patterns and prognostic factorsfor survival[j]. Ann Surg,2000,231(1):51 -58.
  • 6Joensuu H. Risk stratification of patients diagnosed with gastro-intestinal stromal tumor [j]. Hum Pathol, 2008, 39(10):1411-1419.
  • 7DeMatteo RP, Ballman KV, Antonescu CR, et al. Adjuvant ima-tinib mesylate after resection of localised, primary gastrointesti-nal stromal tumour: a randomised, double-blind, plac,eho-ocm-trolled trial[j]. Lancet,2009,373 (9669):1097-1104.
  • 8Joensuu H, Eriksson M, Sundby Hall K, et al. One vs three yearsof adjuvant imatinib for operable gastrointestinal stromal tumor:a randomized trial [j]. JAMA, 2012,307(12):1265-1272.
  • 9Goshima S, Kanematau M,Watanabe H, et al. Hepatic hemangi-oma and metastasis: differentiation with gadoxetate disocli-um-enhanced 3-T MRl[j]. AJR,2010,195(4):941-946.
  • 10Chaudhry UI, DeMatteo RP. Advances in the surgical manage-ment of gastrointestinal stromal tumor [J]. Adv Surg, 2011, 45:197-209.

共引文献18

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部